Subcutaneous apomorphine for parkinsonian patients with psychiatric side effects on oral treatment.
Ray-Chaudhuri
K
K
Abbott
R J
RJ
Millac
P A
PA
D000284:Administration, Oral; D000368:Aged; D001058:Apomorphine / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009460:Neurologic Examination; D010300:Parkinson Disease / Q000188:drug therapy* / Q000523:psychology; D019966:Substance-Related Disorders / Q000517:prevention & control* / Q000523:psychology
D007980:Levodopa; D001058:Apomorphine